Clinical Trial

Parathyroid Adenoma Detection With Rubidium-82 Imaging

Study acronym: PARAGON
Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
Assess the uptake of rubidium-82 in parathyroid adenomas.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-07-25.
Trial Details
NCT Number NCT07099404
Lead Sponsor Matthieu Pelletier-Galarneau, MD MSc
Conditions Parathyroid Adenomas, Hyperparathyroidism, Primary
Enrollment 20 participants
Start Date 2025-11
Primary Completion 2027-09 (estimated)
Study Completion 2028-09 (estimated)
Updated on ClinicalTrials.gov 2025-08-22